{"id":85669,"date":"2023-11-04T19:39:52","date_gmt":"2023-11-04T14:09:52","guid":{"rendered":"http:\/\/finservwealth.com\/divi39s-labs-q2-preview-earnings-likely-to-improve-sequentially-on-better-margins-product-mix\/"},"modified":"2023-11-04T19:39:52","modified_gmt":"2023-11-04T14:09:52","slug":"divi39s-labs-q2-preview-earnings-likely-to-improve-sequentially-on-better-margins-product-mix","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/divi39s-labs-q2-preview-earnings-likely-to-improve-sequentially-on-better-margins-product-mix\/","title":{"rendered":"Divi#39;s Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix"},"content":{"rendered":"<p> A high base from the sales of COVID drug Molnupiravir and soft demand is likely to weigh the year-on-year growth for Divi#39;s Labs<\/p><div id=\"finse-2013616106\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/result-poll\/divi39s-labs-q2-preview-earnings-likely-to-improve-sequentiallybetter-margins-product-mix_17300731.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0A high base from the sales of COVID drug Molnupiravir and soft demand is likely to weigh the year-on-year growth for Divi#39;s Labs A high base from the sales of COVID drug Molnupiravir and soft demand is likely to weigh the year-on-year growth for Divi#39;s Labs\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/result-poll\/divi39s-labs-q2-preview-earnings-likely-to-improve-sequentiallybetter-margins-product-mix_17300731.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> A high base from the sales of COVID drug Molnupiravir and soft demand is likely to weigh the year-on-year growth for Divi#39;s Labs<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/result-poll\/divi39s-labs-q2-preview-earnings-likely-to-improve-sequentiallybetter-margins-product-mix_17300731.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0A high base from the sales of COVID drug Molnupiravir and soft demand is likely to weigh the year-on-year growth for Divi#39;s Labs A high base from the sales of COVID drug Molnupiravir and soft demand is likely to weigh the year-on-year growth for Divi#39;s Labs\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/result-poll\/divi39s-labs-q2-preview-earnings-likely-to-improve-sequentiallybetter-margins-product-mix_17300731.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> A high base from the sales of COVID drug Molnupiravir and soft demand is likely to weigh the year-on-year growth for Divi#39;s Labs<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-85669","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2021\/200x200\/E\/Earnings-2_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/85669","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=85669"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/85669\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=85669"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=85669"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=85669"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}